Allegheny Health Network Cancer Institute — Pittsburgh, Pennsylvania

Allegheny Health Network Cancer Institute is a clinical research site located in Pittsburgh, Pennsylvania, United States 15212.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Allegheny Health Network Cancer Institute has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: Metastatic Breast Cancer, Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B Cell Lymphoma.

Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Miltenyi Biomedicine GmbH, NovoCure Ltd..

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Allegheny Health Network Cancer Institute?

Allegheny Health Network Cancer Institute has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Allegheny Health Network Cancer Institute conducted?

Allegheny Health Network Cancer Institute has 5 clinical trials on record, with 3 currently active. Their work covers Metastatic Breast Cancer, Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B Cell Lymphoma.

Is Allegheny Health Network Cancer Institute accredited by Crixeo Health?

Allegheny Health Network Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Allegheny Health Network Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.